Metabolomics insights into doxorubicin and 5-fluorouracil combination therapy in triple-negative breast cancer: a xenograft mouse model study.
Hassanein MM, Hagyousif YA, Zenati RA, Al-Hroub HM, Khan FM, Abuhelwa AY, Alzoubi KH, Soares NC, El-Huneidi W, Abu-Gharbieh E, Omar H, Zaher DM, Bustanji Y, Semreen MH.
Hassanein MM, et al. Among authors: khan fm.
Front Mol Biosci. 2025 Jan 13;11:1517289. doi: 10.3389/fmolb.2024.1517289. eCollection 2024.
Front Mol Biosci. 2025.
PMID: 39872164
Free PMC article.